Abstract:Metal-site Trp/His interactions are crucial to diverse metalloprotein functions. This paper presents a study using metal-motif mimicry to capture and dissect the static and transient components of physicochemical properties underlying the Trp/His aromatic side-chain noncovalent interactions across the first- and second-coordination spheres of biometal ions. Modular biomimetic constructs, EDTA-(L-Trp, L-His) or EWH and DTPA-(L-Trp, L-His) or DWH, featuring a function-significant Trp/His pair, enabled extracting the putative hydrophobic/hydrophilic aromatic interactions surrounding metal centers. Fluorescence, circular dichroism (CD) spectroscopic titrations and ESI mass spectrometry demonstrated that both the constructs stoichiometrically bind to Ca(2+), Co(2+), Cu(2+), Ni(2+), Mn(2+), Zn(2+), Cd(2+), and Fe(2+), and such binding was strongly coupled to stereospecific side-chain structure reorientations of the Trp indole and His imidazole rings. A mechanistic dichotomy corresponding to the participation of the indole unit in the binding event was revealed by a scaffold-platform correlation of steady-state fluorescence-response landscape, illuminating that secondary-coordination-sphere ligand cation-π interactions were immediately followed by subsequent transient physicochemical processes including through-space energy transfer, charge transfer and/or electron transfer, depending on the type of metals. The fluorescence quenching of Trp side chain by 3d metal ions can be ascribed to through-space d-π interactions. While the fluorescence titration was capable of illuminating a two-component energetic model, clean isosbestic/isodichroic points in the CD titration spectra indicated that the metallo-constructs, such as Cu(2+)-EWH complex, fold thermodynamically by means of a two-state equilibrium. Further, the metal-ion dependence of Trp conformational variation in the modular architecture of metal-bound scaffolds was evidenced unambiguously by the CD spectra and supported by MMFF calculations; both were capable of distinguishing between the coordination geometry and the preference for metal binding mode. The study thus helps understand how aromatic rings around metal-sites have unique capabilities through the control of the spatiotemporal distribution of noncovalent interaction elements to achieve diverse chemical functionality.

Not All Binding Sites Are Equal: Site Determination and Folding State Analysis of Gas‐phase Protein–Metallodrug Adducts

Mass Spectrometric Quantification of the Binding Ratio of Metal-Based Anticancer Complexes with Protein Thiols.

Time-series analysis of rhenium(I) organometallic covalent binding to a model protein for drug development

Exploring the binding properties of DNA/BSA and cytotoxicity studies with new terpyridine-ester-based metal complexes (M = Fe(III), Ni(II), Cu(II) and Ru(III)) - A comparative analysis

Structural Approaches to Probing Metal Interaction with Proteins

Competitive Binding Sites of a Ruthenium Arene Anticancer Complex on Oligonucleotides Studied by Mass Spectrometry: Ladder-Sequencing versus Top-Down

Dual Inhibitory Pathways of Metallofullerenol Gd@C82(OH)22 on Matrix Metalloproteinase-2: Molecular Insight into Drug-Like Nanomedicine

Inhibition of CYP2C8 by Metallofullerenol Gd@C82(OH)22 Through Blocking Substrate Channels and Substrate Recognition Sites

Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking

Binding Sites of [ru(bpy)2(h2o)2](bf4)2 with Sulfur- and Histidine-Containing Peptides Studied by Electrospray Ionization Mass Spectrometry and Tandem Mass Spectrometry.

A Comparative Study on Interactions of Cisplatin and Ruthenium Arene Anticancer Complexes with Metallothionein Using MALDI-TOF-MS

Binding to Dna Purine Base and Structure-Activity Relationship of A Series of Structurally Related Ru(Ii) Antitumor Complexes: A Theoretical Study

Binding of RuCp complexes with human apo-transferrin: fluorescence spectroscopy and molecular docking methods

Protein Metalation by Medicinal Gold Compounds: Identification of the Main Features of the Metalation Process through ESI MS Experiments

Chemical Proteomics-based Target Prioritization through a Residue Agnostic Ligandability Assessment Platform

Mass Spectrometric Strategies to Improve the Identification of Pt(Ii)-Modification Sites on Peptides and Proteins

Quantification of Bindings of Organometallic Ruthenium Complexes to GSTπ by Mass Spectrometry.

Platinum stabilises a molten‐globule conformation of a small globular cytosolic protein SUMO1

Biometal Binding-Site Mimicry with Modular, Hetero-Bifunctionally Modified Architecture Encompassing a Trp/His Motif: Insights into Spatiotemporal Noncovalent Interactions from a Comparative Spectroscopic Study.

Inferring metal binding sites in flexible regions of proteins

Metalloproteomics for molecular target identification of protein-binding anticancer metallodrugs.